DK1622940T3 - Analyse og anvendelse af PAR1-polymorphismer til risikovurdering af kardiovaskulære sygdomme - Google Patents

Analyse og anvendelse af PAR1-polymorphismer til risikovurdering af kardiovaskulære sygdomme

Info

Publication number
DK1622940T3
DK1622940T3 DK04727840T DK04727840T DK1622940T3 DK 1622940 T3 DK1622940 T3 DK 1622940T3 DK 04727840 T DK04727840 T DK 04727840T DK 04727840 T DK04727840 T DK 04727840T DK 1622940 T3 DK1622940 T3 DK 1622940T3
Authority
DK
Denmark
Prior art keywords
par1
polymorphisms
analysis
cardiovascular disease
risk assessment
Prior art date
Application number
DK04727840T
Other languages
English (en)
Inventor
Detlef Kozian
Joerg Czech
Karl-Ernst Siegler
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1622940T3 publication Critical patent/DK1622940T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK04727840T 2003-04-24 2004-04-16 Analyse og anvendelse af PAR1-polymorphismer til risikovurdering af kardiovaskulære sygdomme DK1622940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318496A DE10318496A1 (de) 2003-04-24 2003-04-24 Analyse und Verwendung von PAR 1 Polymorphismen zur Risikoabschätzung für kardiovaskuläre Erkrankungen
PCT/EP2004/004035 WO2004094470A1 (de) 2003-04-24 2004-04-16 Analyse und verwendung von par 1 polymorphismen zur risikoabschätzung für kardiovaskuläre erkrankungen

Publications (1)

Publication Number Publication Date
DK1622940T3 true DK1622940T3 (da) 2009-01-12

Family

ID=33304897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04727840T DK1622940T3 (da) 2003-04-24 2004-04-16 Analyse og anvendelse af PAR1-polymorphismer til risikovurdering af kardiovaskulære sygdomme

Country Status (16)

Country Link
EP (1) EP1622940B1 (da)
JP (1) JP4728949B2 (da)
KR (1) KR20060006939A (da)
CN (1) CN1791613A (da)
AT (1) ATE407145T1 (da)
AU (1) AU2004232459B2 (da)
BR (1) BRPI0409688A (da)
CA (1) CA2522815A1 (da)
DE (2) DE10318496A1 (da)
DK (1) DK1622940T3 (da)
ES (1) ES2312990T3 (da)
IL (1) IL171477A (da)
MX (1) MXPA05011464A (da)
NO (1) NO20055538L (da)
RU (1) RU2380422C2 (da)
WO (1) WO2004094470A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2322193C1 (ru) * 2006-12-04 2008-04-20 Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации Способ оценки генетического риска сердечно-сосудистых заболеваний у спортсменов
RU2453606C2 (ru) * 2010-07-16 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Способ расширенного скрининга предрасположенности к сердечно-сосудистым заболеваниям и биочип для осуществления этого способа

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819889A1 (de) * 1998-05-04 1999-11-11 Fraunhofer Ges Forschung Verfahren zur Isolierung von Nucleinsäuren
US6511831B1 (en) * 1998-05-04 2003-01-28 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Electrical integrated nucleic acid isolation, purification and detection
US6322980B1 (en) * 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence

Also Published As

Publication number Publication date
EP1622940B1 (de) 2008-09-03
RU2380422C2 (ru) 2010-01-27
JP2007534293A (ja) 2007-11-29
ES2312990T3 (es) 2009-03-01
DE502004007990D1 (de) 2008-10-16
EP1622940A1 (de) 2006-02-08
JP4728949B2 (ja) 2011-07-20
CN1791613A (zh) 2006-06-21
DE10318496A1 (de) 2004-11-25
KR20060006939A (ko) 2006-01-20
CA2522815A1 (en) 2004-11-04
MXPA05011464A (es) 2006-03-08
RU2005136430A (ru) 2006-04-20
AU2004232459A1 (en) 2004-11-04
NO20055538L (no) 2005-11-23
WO2004094470A1 (de) 2004-11-04
IL171477A (en) 2010-11-30
AU2004232459B2 (en) 2010-11-11
ATE407145T1 (de) 2008-09-15
BRPI0409688A (pt) 2006-04-18

Similar Documents

Publication Publication Date Title
WO2009117122A3 (en) Genetic analysis
WO2007070280A3 (en) Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
NZ600235A (en) Methods and compositions for the assessment of drug response
DK1490490T3 (da) Antisense IAP--nukleobase-oligomerer og anvendelser deraf
EP1572118A4 (en) METHOD AND COMPOSITIONS FOR TREATING CANCER WITH 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
DK1692102T3 (da) Sammensætninger og fremgangsmåder til at påvise og behandle sygdomme og tilstande knyttet til chemokinreceptorer
WO2007070640A3 (en) Use of roma for characterizing genomic rearrangements
MA30485B1 (fr) Aminothiazoles et leurs utilisations
ATE513929T1 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
WO2004026107A3 (en) Kits and methods for assessing skin health
WO2006037462A3 (en) Cancer markers
EP1948831A4 (en) ALZHEIMER ASSOCIATED GENETIC POLYMORPHISMS, DETECTION METHOD AND USE THEREOF
WO2003054166A3 (en) Nucleotide polymorphisms associated with osteoarthritis
NO20073636L (no) Sammensetninger og metoder til a behandle mentale lidelser
WO2005047536A3 (en) Detection of genomic amplification and deletion in cancer
NO20054913L (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
SI1730315T1 (sl) Polimorfizmi v genu NOD2/CARD15
MX2009008788A (es) Poliformismos de serpine1 son predictivos de respuesta a administracion de proteina c activada y riesgo de muerte.
NO20055538L (no) Analyse og anvendelse av PARI polymorfismer for risikoestimering av kardiovaskulaere sykdommer
WO2007120156A3 (en) Animal models of long qt syndrome and uses thereof
NO20053903D0 (no) Nukleotidlipidesterderivater.
WO2008018789A3 (en) Methods and means for diagnosing and treatment of osteoarthritis
WO2005112568A3 (en) Haplotype markers and methods of using the same to determine response to treatment
AR060955A1 (es) Utilizacion del gen adamts4 y de los polimorfismos de proteina